Hiv Aids Virus Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Aids Virus Biography 

Source (google.com.pk)

Hiv Aids Virus Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Cause Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Cause Of Aids Biography 

Source (google.com.pk)

Cause Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Africa Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Africa Aids Biography 

Source (google.com.pk)

Africa Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Hotline Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wall papers photos

Aids Hotline Biography 

Source (google.com.pk)

Aids Hotline Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wall papers photos

Origin Of Ads Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Origin Of Ads Biography 

Source (google.com.pk)

Origin Of Ads Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Symptom Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Symptom Of Aids Biography

Source (google.com.pk)

Symptom Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

What Are Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

What Are Aids Biography

Source (google.com.pk)

What Are Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Epidemic Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Epidemic Biography

Source (google.com.pk)

Aids Epidemic Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Testing Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Testing Biography

Source (google.com.pk)

Aids Testing Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Ribbon Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Ribbon Biography

Source (google.com.pk)

Aids Ribbon Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Aids News Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Aids News Biography

Source (google.com.pk)

Hiv Aids News Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Causes Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Causes Biography

Source (google.com.pk)

Aids Causes Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Signs And Symptoms Of Hiv Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Signs And Symptoms Of Hiv Biography

Source (google.com.pk)
Signs And Symptoms Of Hiv Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Symptoms In Men Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Symptoms In Men Biography

Source (google.com.pk)

Hiv Symptoms In Men Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Transmission Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Transmission Biography

Source (google.com.pk)

Aids Transmission Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Foundation Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Foundation biography

source (google.com.pk)

Aids Foundation Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Transmission Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Transmission biography

source (google.com.pk)

Aids Transmission Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Aids Causes Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Aids Causes biography

source (google.com.pk)

Hiv Aids Causes Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv And Aids Symptoms Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv And Aids biography

source (google.com.pk)

Hiv And Aids Symptoms Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Charity Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Charity Aids biography

source (google.com.pk)

Aids Charity Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Symtoms Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Symtoms Of Aids biography

source (google.com.pk)

Symtoms Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

 Aids Symptoms biography

source (google.com.pk)

 Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Research Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Research biography

source (google.com.pk)

Aids Research Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Stop Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Stop Aids biography

source (google.com.pk)

Stop Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Vaccine Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Vaccine biography

source (google.com.pk)

Aids Vaccine Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Feline Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Feline Aids biography

source (google.com.pk)

Feline Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Symptoms Of Hiv Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Symptoms Of Hiv biography

source (google.com.pk)

Symptoms Of Hiv Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Symptoms In Men Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Symptoms In Men biography

source (google.com.pk)

Aids Symptoms In Men Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Aids Images Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Aids Images biography

source (google.com.pk)

Hiv Aids Images Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Symptoms Of Hiv Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Symptoms Of Hiv Aids biography

source (google.com.pk)

Symptoms Of Hiv Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

People With Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

People With Aids biography

source (google.com.pk)

People With Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids News Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids News biography

source (google.com.pk)

Aids News Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Organizations Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Organizations biography

source (google.com.pk)

Aids Organizations Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

About Hiv Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

About Hiv Aids biography

source (google.com.pk)

About Hiv Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Definition Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Definition Of Aids biography

source (google.com.pk)

Definition Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Africa Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Africa biography

source (google.com.pk)

Aids Africa Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Effects Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Effects Of Aids biography

source (google.com.pk)

Effects Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Wiki Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Wiki Aids biography

source (google.com.pk)

Aids Wiki Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids History Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids History biography

source (google.com.pk)
Aids History Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Pictures Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Pictures Of Aids biography

source (google.com.pk)

Pictures Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Aids History Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Aids History biography

source (google.com.pk)

Hiv Aids History Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Definition Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Definition biography

source (google.com.pk)

Aids Definition Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

What Causes Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

What Causes Aids biography

source (google.com.pk)

What Causes Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

About Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

About Aids biography

source (google.com.pk)

About Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Treatment Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Treatment Of Aids biography

source (google.com.pk)

Treatment Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Aids Awareness Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv Aids Awareness biography

source (google.com.pk)

Hiv Aids Awareness Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Signs Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Signs Of Aids biography

source (google.com.pk)
 The first African woman to win the Nobel Peace Prize, Wangari Maatha of Kenya, spoke out on the AIDS virus saying it was man-made and deliberately created as a weapon of bio-warfare.

"In fact it (the HIV virus) is created by a scientist for biological warfare,” she said. "Why has there been so much secrecy about AIDS? When you ask where did the virus come from, it raises a lot of flags. That makes me suspicious,” Maathai said.

The Kenya based East Africa Standard reported that in response to questions from Asian and European media, she said, "I want to dedicate the prize the African woman. I want to hold and embrace her. She has suffered so much and I feel this is an honor to her.

"Although I am a biologist, I have not done any research. I may not be able to say who developed the (HIV) virus but it was meant to wipe out the Black race," she continued.

"When she first blamed the HIV/Aids on 'some sadistic scientists, Professor Maathai kicked a storm, leaving some experts outraged and others supporting her," the Standard reported.

"Initially, said Maathai, HIV/Aids was only concentrated in selected spots in the continent, only afflicting the 'undesirable classes.' She insisted that some scientists from the developed world deliberately researched and developed the virus in order to "punish the Blacks".

"I cannot prove this but everybody knows that there are biological weapons. America invaded Iraq because they believed such weapons existed," said Maathai.

Africa accounts for 25 million out of the estimated 38 million people across the world infected with HIV/AIDS, and the vast majority of infected Africans are women, according to UNAIDS estimates.

“Some say that AIDS came from the monkeys, and I doubt that because we have been living with monkeys (since) time immemorial, others say it was a curse from God, but I say it cannot be that.

“Black people are dying more than any other people in this planet,” Maathai told a press conference in Nairobi a day after winning the prize for her work in human rights and reversing deforestation across Africa.

“It’s true that there are some people who create agents to wipe out other people. If there were no such people, we could have not have invaded Iraq,” she said.

“We invaded Iraq because we believed that Saddam Hussein had made, or was in the process of creating agents of biological warfare,” said Maathai, who is also the Kenyan Deputy Environment and Natural Resources Minister.

The unspoken truth is that both the United Nations and the United States have promoted so-called "population control" for decades. What better agent for the reduction of population than a man-made virus that will take care of millions of so-called "useless eaters"?

AIDS certainly fits the bill. But nobody is talking about its "efficiency."

END
Human Immunodeficiency Virus (HIV) is a lentivirus, a group of retroviruses, that causes slow development of acquired immunodeficiency syndrome (AIDS). This results in immune system failure and increased suscepibility to life-threatening infections. HIV occurs as two types: HIV-type 1 (HIV-1) and HIV-type 2 (HIV-2). The HIV-2 strain is limited to Western and Central Africa.[1] The HIV-1 type acts as the primary cause of (AIDS) throughout the world.[1] The focus of this text is on HIV-1. Virus transmission occurs through transfer of blood, vaginal fluid, semen, pre-ejaculate, or breast milk. The primary modes of transmission are unprotected sex, breast milk, contaminated needles, and transmission at birth by an infected mother.

The most recently reported prevalence in the United States of those living with diagnosed or undiagnosed HIV infection was 1.1 million adults and adolescents (prevalence rate: 447.8 per 100,000 population). [2] The latest number of new cases per year in the United States has been reported at an incidence of 56,300.[3]

Fold
Table of Contents
OVERVIEW
NORMAL IMMUNE SYSTEM
Innate Immunity
Adaptive Immunity
Humoral Immunity
Cell-Mediated Immunity
General Immune Response to Infection
Virus Structure - HIV
HIV Targets[1]
HIV Tropism
HIV Replication (See Fig. 1)
Step 1: Host cell binding and virus entry
Step 2: Uncoating the viral capsid
Step 3: Transcription
Step 4: Integration into host cell DNA
Step 5: Virus protein synthesis and assembly
Step 6: Exocytosis or storage within the host cell
Mutations and latency as inhibiting factors of complete HIV eradication
PATHOGENESIS OF HIV & IMMUNE RESPONSE
Immune Response to HIV-1
Cytokines
Mitochondria & Apoptosis in HIV infection
HIV and Neuroendocrine System
HPA Axis (See Fig. 3)
Cortisol
Adrenal Androgens
Heat Shock Proteins
Clinical Manifestations
Animal Models
Pharmacology
HIV Controllers vs. Progressors & Future Research
Conclusion
Comments
NORMAL IMMUNE SYSTEM

In order to thoroughly understand HIV/AIDs, it is paramount to understand the normal immune system response to infection and thus, how the HIV virus disrupts this system. The human body has typical physical barriers which protect us from pathogens including the gut, skin, urinary tract and mucous membranes of the bronchi. The organism is protected from infection and disease when the immune system is working properly; however, failure of the system can result in infection or disease that is localized or systemic. Due to the diversity of existing pathogens, the immune system has to respond in a variety of ways and the response depends on the type of antigen presented. Two immune responses work together to prevent entry of pathogens and destroy them upon penetration into the organism: Innate immunity and Adaptive/Acquired immunity.[4]

Innate Immunity

The innate immunity is the body’s first line of defense involving the skin and mucosal barriers as well as a nonspecific inflammatory response. [4] The main purpose of innate immunity is to rapidly contain an infection or pathogen once present in order to slow down the replication and spread of the pathogen. If the pathogen cannot be destroyed by the innate system alone, the adaptive immune system is mobilized. Once the adaptive response is initiated, the innate immunity also plays a critical role for amplifying, modulating, and sustaining the adaptive immune responses.[5]

Signs Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Information About Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Information About Aids biography

source (google.com.pk)
HIV-1, which is responsible for the vast majority of AIDS cases worldwide, is divided into three groups -- the "major" group M, and the much rarer "outlier" group O and "new" group N -- that have diverged over years of mutation and evolution. Within the M group -- which makes up 90 percent of all infections worldwide -- there are at least nine strains, known as "clades," of HIV-1 that are constantly mutating and merging with each other, creating yet more new varieties. "The M group epidemiologically has overwhelmed what else is out there," says Dr. Beatrice Hahn of the University of Alabama-Birmingham, who has conducted much of the research into HIV's origin. HIV-2, on the other hand, is not as virulent and largely confined to West Africa, where it originated.

In May 2006, an international group of researchers led by Hahn answered two major questions about the origin of HIV-1 M, the deadliest and most widespread form of the virus: Where was its cradle, and what kind of chimp did it come from? Answering the questions was literally messy work -- researchers collected 599 waste samples from wild chimpanzees and analyzed the viral particles they contained -- but the results were immaculate. Three populations of Pan troglodytes troglodytes living in southern Cameroon provided the crucial data. Two of those populations currently carry SIVs that are molecular dead ringers for HIV-1 M, while many chimps in the third group are infected with an SIV remarkably similar to HIV-1 N. Group O's simian sibling is probably lurking in other chimp populations in West Central Africa, says Hahn, adding that she has "a pretty good idea where it's going to be … and we're going to find it."

The research puts to rest decades of speculation about the birthplace of most types of HIV and their animal "reservoir" in the wild. But there are still many questions that haven't yet been definitively settled -- questions such as:

When did HIV-1 first start spreading in humans?

HIV-1 is surprisingly old, and it probably "debuted" in humans at least three separate times -- one for each subtype, M, N, and O. Scientists' best guess is that the precursor of the most common "M" virus jumped from the Cameroon chimps to humans sometime before 1931. Using samples of HIV-infected tissue harvested over the last three decades, virologist Dr. Bette Korber of Los Alamos National Laboratory has calculated that an ancestral form of HIV started spreading, slowly at first, in humans about 75 years ago. The actual jump from chimps to humans probably occurred shortly before that, says Hahn: "There's no reason to believe this was just lingering around in people."

Korber's model estimates a virus' age based on how extensively different strains have mutated. HIV is an unusual virus; it changes its DNA by both mutation and, more often, recombination, when two strains merge within the body and exchange genetic material. Some scientists refer to this process as "viral sex," and it may partially explain why it is so hard for scientists to make a treatment or vaccine. Korber's model does not take recombination into account, but given a virus' DNA configuration, it can roughly predict the age of that strain. Korber has tested the oldest known HIV sample, taken in 1959, and derived the 1931 estimate.

Why do scientists look at recent samples of HIV to determine the virus' overall age? Wouldn't it be better to use older samples that haven't had as much time to mutate?

It would, but scientists don't have that luxury. Other than the 1959 sample, there are very few preserved specimens of HIV-infected tissue that predate the early '80s, when the virus was first recognized by health authorities. Researchers still hope there are forgotten samples in African freezers. "There has to be some serum or plasma somewhere, and given modern technology we could fish out the virus," says Dr. David Ho, director of the Aaron Diamond AIDS Research Center and one of the world's leading authorities on HIV.

But even if those samples are found someday, they won't necessarily yield definite answers about the virus' age, says Korber: "Often, you can't get anything out of samples like that." Most African samples are made of blood serum, and serum samples contain viral RNA, which degrades much faster than the DNA found in tissue samples. In fact, says Ho, the 1959 sample, which was sequenced by his laboratory, was kept in a freezer but still didn't survive the ravages of time. "It was completely dried up," he says. "We were only able to get small pieces [of genetic material], and we had to stitch them together."

So scientists have estimated when and where the most deadly type of HIV started infecting humans -- but how did it do that?

Most AIDS researchers believe that the "bushmeat trade" allowed the HIV-1 virus, and separately HIV-2, to enter the human bloodstream several times. Hunters who kill and butcher chimps and monkeys are regularly exposed to animal blood teeming with SIVs. If the hunters have cuts, bites, or scratches -- and given the nature of their work they almost always do -- they can catch the viruses from their prey. Hunters going after chimps in Cameroon could have caught the first strains of HIV-1. Sooty mangabeys, hunted and kept as pets in West Africa, could have transmitted HIV-2 to humans.

Africans have hunted chimps and monkeys and kept them as pets for centuries; they've presumably been exposed to SIVs during most of that time. But the conditions needed for HIV to spread widely weren't in place until after the continent was colonized and urbanized. The first victims would have found it easier to unwittingly spread the virus to sexual partners far and wide as roads and vehicles started connecting previously isolated villages and cities. Hospitals may have played a role, too. Strapped for cash, some of them probably re-used dirty needles, unknowingly infecting patients in the process.

Are there other theories about how the virus could have gotten into humans?

There are several competing theories, ranging from implausible conspiracies to arguments grounded in extensive research. The best-known of the latter, the "OPV/AIDS" theory, was exhaustively detailed in the 1999 book The River, by author Edward Hooper. As many as a million Africans were given oral polio vaccines (OPV) between 1957 and 1960. Hooper says witnesses have told him that a few batches of those vaccines were "grown" in chimp cells at a lab in Kisangani, a city in the Democratic Republic of the Congo -- and that the chimp cells, and thus the vaccines, could have contained SIVs that jumped into humans. "There are highly significant correlations between the places where this vaccine was administered and the places where … AIDS first appeared on the planet four to 20 years later," Hooper says.

Scientists' best guess is that the precursor of the most common 'M' virus jumped from the Cameroon chimps to humans sometime before 1931.
The majority of HIV researchers subscribe to the bushmeat theory and raise several arguments against the OPV theory. Hahn's recent research confirming that HIV-1 M and N arose from Pan troglodytes troglodytes chimps in Cameroon presents one problem: The Kisangani lab is in the Democratic Republic of the Congo, and it's home to a different subspecies of chimp than the one that was the source of HIV-1 M and N. However, it is possible that the chimps used in the Kisangani experiments were not from the area. In the spring of 2006, Hooper found a paper indicating that at least one of eight chimps at the Kisangani lab was a Pan troglodytes troglodytes.

The 1959 sample also presents a problem for the OPV theory. Judging by how fast the virus mutates, it had already diverged significantly from its SIV ancestors by the time doctors extracted it from a patient. However, the African polio vaccination program had begun only two years earlier, so under the OPV theory, the virus would have had only those two years in which to evolve. Dr. Ho, who sequenced the sample, says it looks like the virus has been around a lot longer than that.

Proponents of each theory have acknowledged (albeit grudgingly) that the other is scientifically possible. In the last two years researchers have found that both "simian foamy viruses" and at least two types of retroviruses can and do jump from monkeys to humans via hunting and butchery. And no one doubts that a vaccine cultured in primate cells could be contaminated with a primate virus. Some early polio vaccines contained SV40, a simian virus discovered in 1960, and the RNA virus that causes Marburg hemorrhagic fever.

The question is not whether either scenario could have happened -- it's which one did. To truly disprove the OPV theory, Hahn says, researchers would have to find HIV-infected human tissue samples that predate the polio vaccine trials. To prove the OPV/AIDS theory, on the other hand, they'd have to find the ancestral SIV in batches of the vaccine that were made in Kisangani. Neither of those things has happened, and it's possible they never will.

Why do we care? Does all this research into how the virus got started tell us anything about how to stop it?


Hunting chimps in West Central Africa.
Research into the HIV's origins may eventually yield practical results. It could help scientists understand why HIV's viral ancestor, SIV, doesn't kill or even sicken chimps who carry it. With that knowledge, researchers might be able to make drugs with fewer side effects, or broad-spectrum vaccines that protect against all the strains of the disease that infect people today.

Korber suggests that in an era of emerging diseases, looking back on the virus' shadowy origins offers a "history lesson," or perhaps even a fable, with a moral attached. By the time doctors realized that HIV/AIDS existed, it had already taken up permanent residence in humans. They couldn't have known about it before then, but, Korber says, at least now they know to be wary as the virus continues its shape-shifting spread around the globe. "The fact that it could be with us for quite a long time before we even realized it was there is kind of eye-opening," she says. "I think it's something to keep us on our toes. It helps us understand that we can be surprised." And of course, HIV research may have a few surprises left for us, too.

Information About Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv & Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Hiv & Aids Aids biography

source (google.com.pk)
 The first African woman to win the Nobel Peace Prize, Wangari Maatha of Kenya, spoke out on the AIDS virus saying it was man-made and deliberately created as a weapon of bio-warfare.

"In fact it (the HIV virus) is created by a scientist for biological warfare,” she said. "Why has there been so much secrecy about AIDS? When you ask where did the virus come from, it raises a lot of flags. That makes me suspicious,” Maathai said.

The Kenya based East Africa Standard reported that in response to questions from Asian and European media, she said, "I want to dedicate the prize the African woman. I want to hold and embrace her. She has suffered so much and I feel this is an honor to her.

"Although I am a biologist, I have not done any research. I may not be able to say who developed the (HIV) virus but it was meant to wipe out the Black race," she continued.

"When she first blamed the HIV/Aids on 'some sadistic scientists, Professor Maathai kicked a storm, leaving some experts outraged and others supporting her," the Standard reported.

"Initially, said Maathai, HIV/Aids was only concentrated in selected spots in the continent, only afflicting the 'undesirable classes.' She insisted that some scientists from the developed world deliberately researched and developed the virus in order to "punish the Blacks".

"I cannot prove this but everybody knows that there are biological weapons. America invaded Iraq because they believed such weapons existed," said Maathai.

Africa accounts for 25 million out of the estimated 38 million people across the world infected with HIV/AIDS, and the vast majority of infected Africans are women, according to UNAIDS estimates.

“Some say that AIDS came from the monkeys, and I doubt that because we have been living with monkeys (since) time immemorial, others say it was a curse from God, but I say it cannot be that.

“Black people are dying more than any other people in this planet,” Maathai told a press conference in Nairobi a day after winning the prize for her work in human rights and reversing deforestation across Africa.

“It’s true that there are some people who create agents to wipe out other people. If there were no such people, we could have not have invaded Iraq,” she said.

“We invaded Iraq because we believed that Saddam Hussein had made, or was in the process of creating agents of biological warfare,” said Maathai, who is also the Kenyan Deputy Environment and Natural Resources Minister.

The unspoken truth is that both the United Nations and the United States have promoted so-called "population control" for decades. What better agent for the reduction of population than a man-made virus that will take care of millions of so-called "useless eaters"?

AIDS certainly fits the bill. But nobody is talking about its "efficiency."

END
Human Immunodeficiency Virus (HIV) is a lentivirus, a group of retroviruses, that causes slow development of acquired immunodeficiency syndrome (AIDS). This results in immune system failure and increased suscepibility to life-threatening infections. HIV occurs as two types: HIV-type 1 (HIV-1) and HIV-type 2 (HIV-2). The HIV-2 strain is limited to Western and Central Africa.[1] The HIV-1 type acts as the primary cause of (AIDS) throughout the world.[1] The focus of this text is on HIV-1. Virus transmission occurs through transfer of blood, vaginal fluid, semen, pre-ejaculate, or breast milk. The primary modes of transmission are unprotected sex, breast milk, contaminated needles, and transmission at birth by an infected mother.

The most recently reported prevalence in the United States of those living with diagnosed or undiagnosed HIV infection was 1.1 million adults and adolescents (prevalence rate: 447.8 per 100,000 population). [2] The latest number of new cases per year in the United States has been reported at an incidence of 56,300.[3]

Fold
Table of Contents
OVERVIEW
NORMAL IMMUNE SYSTEM
Innate Immunity
Adaptive Immunity
Humoral Immunity
Cell-Mediated Immunity
General Immune Response to Infection
Virus Structure - HIV
HIV Targets[1]
HIV Tropism
HIV Replication (See Fig. 1)
Step 1: Host cell binding and virus entry
Step 2: Uncoating the viral capsid
Step 3: Transcription
Step 4: Integration into host cell DNA
Step 5: Virus protein synthesis and assembly
Step 6: Exocytosis or storage within the host cell
Mutations and latency as inhibiting factors of complete HIV eradication
PATHOGENESIS OF HIV & IMMUNE RESPONSE
Immune Response to HIV-1
Cytokines
Mitochondria & Apoptosis in HIV infection
HIV and Neuroendocrine System
HPA Axis (See Fig. 3)
Cortisol
Adrenal Androgens
Heat Shock Proteins
Clinical Manifestations
Animal Models
Pharmacology
HIV Controllers vs. Progressors & Future Research
Conclusion
Comments
NORMAL IMMUNE SYSTEM

In order to thoroughly understand HIV/AIDs, it is paramount to understand the normal immune system response to infection and thus, how the HIV virus disrupts this system. The human body has typical physical barriers which protect us from pathogens including the gut, skin, urinary tract and mucous membranes of the bronchi. The organism is protected from infection and disease when the immune system is working properly; however, failure of the system can result in infection or disease that is localized or systemic. Due to the diversity of existing pathogens, the immune system has to respond in a variety of ways and the response depends on the type of antigen presented. Two immune responses work together to prevent entry of pathogens and destroy them upon penetration into the organism: Innate immunity and Adaptive/Acquired immunity.[4]

Innate Immunity

The innate immunity is the body’s first line of defense involving the skin and mucosal barriers as well as a nonspecific inflammatory response. [4] The main purpose of innate immunity is to rapidly contain an infection or pathogen once present in order to slow down the replication and spread of the pathogen. If the pathogen cannot be destroyed by the innate system alone, the adaptive immune system is mobilized. Once the adaptive response is initiated, the innate immunity also plays a critical role for amplifying, modulating, and sustaining the adaptive immune responses.[5]

Hiv & Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Causes Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Causes Of Aids biography

source (google.com.pk)
HIV-1, which is responsible for the vast majority of AIDS cases worldwide, is divided into three groups -- the "major" group M, and the much rarer "outlier" group O and "new" group N -- that have diverged over years of mutation and evolution. Within the M group -- which makes up 90 percent of all infections worldwide -- there are at least nine strains, known as "clades," of HIV-1 that are constantly mutating and merging with each other, creating yet more new varieties. "The M group epidemiologically has overwhelmed what else is out there," says Dr. Beatrice Hahn of the University of Alabama-Birmingham, who has conducted much of the research into HIV's origin. HIV-2, on the other hand, is not as virulent and largely confined to West Africa, where it originated.

In May 2006, an international group of researchers led by Hahn answered two major questions about the origin of HIV-1 M, the deadliest and most widespread form of the virus: Where was its cradle, and what kind of chimp did it come from? Answering the questions was literally messy work -- researchers collected 599 waste samples from wild chimpanzees and analyzed the viral particles they contained -- but the results were immaculate. Three populations of Pan troglodytes troglodytes living in southern Cameroon provided the crucial data. Two of those populations currently carry SIVs that are molecular dead ringers for HIV-1 M, while many chimps in the third group are infected with an SIV remarkably similar to HIV-1 N. Group O's simian sibling is probably lurking in other chimp populations in West Central Africa, says Hahn, adding that she has "a pretty good idea where it's going to be … and we're going to find it."

The research puts to rest decades of speculation about the birthplace of most types of HIV and their animal "reservoir" in the wild. But there are still many questions that haven't yet been definitively settled -- questions such as:

When did HIV-1 first start spreading in humans?

HIV-1 is surprisingly old, and it probably "debuted" in humans at least three separate times -- one for each subtype, M, N, and O. Scientists' best guess is that the precursor of the most common "M" virus jumped from the Cameroon chimps to humans sometime before 1931. Using samples of HIV-infected tissue harvested over the last three decades, virologist Dr. Bette Korber of Los Alamos National Laboratory has calculated that an ancestral form of HIV started spreading, slowly at first, in humans about 75 years ago. The actual jump from chimps to humans probably occurred shortly before that, says Hahn: "There's no reason to believe this was just lingering around in people."

Korber's model estimates a virus' age based on how extensively different strains have mutated. HIV is an unusual virus; it changes its DNA by both mutation and, more often, recombination, when two strains merge within the body and exchange genetic material. Some scientists refer to this process as "viral sex," and it may partially explain why it is so hard for scientists to make a treatment or vaccine. Korber's model does not take recombination into account, but given a virus' DNA configuration, it can roughly predict the age of that strain. Korber has tested the oldest known HIV sample, taken in 1959, and derived the 1931 estimate.

Why do scientists look at recent samples of HIV to determine the virus' overall age? Wouldn't it be better to use older samples that haven't had as much time to mutate?

It would, but scientists don't have that luxury. Other than the 1959 sample, there are very few preserved specimens of HIV-infected tissue that predate the early '80s, when the virus was first recognized by health authorities. Researchers still hope there are forgotten samples in African freezers. "There has to be some serum or plasma somewhere, and given modern technology we could fish out the virus," says Dr. David Ho, director of the Aaron Diamond AIDS Research Center and one of the world's leading authorities on HIV.

But even if those samples are found someday, they won't necessarily yield definite answers about the virus' age, says Korber: "Often, you can't get anything out of samples like that." Most African samples are made of blood serum, and serum samples contain viral RNA, which degrades much faster than the DNA found in tissue samples. In fact, says Ho, the 1959 sample, which was sequenced by his laboratory, was kept in a freezer but still didn't survive the ravages of time. "It was completely dried up," he says. "We were only able to get small pieces [of genetic material], and we had to stitch them together."

So scientists have estimated when and where the most deadly type of HIV started infecting humans -- but how did it do that?

Most AIDS researchers believe that the "bushmeat trade" allowed the HIV-1 virus, and separately HIV-2, to enter the human bloodstream several times. Hunters who kill and butcher chimps and monkeys are regularly exposed to animal blood teeming with SIVs. If the hunters have cuts, bites, or scratches -- and given the nature of their work they almost always do -- they can catch the viruses from their prey. Hunters going after chimps in Cameroon could have caught the first strains of HIV-1. Sooty mangabeys, hunted and kept as pets in West Africa, could have transmitted HIV-2 to humans.

Africans have hunted chimps and monkeys and kept them as pets for centuries; they've presumably been exposed to SIVs during most of that time. But the conditions needed for HIV to spread widely weren't in place until after the continent was colonized and urbanized. The first victims would have found it easier to unwittingly spread the virus to sexual partners far and wide as roads and vehicles started connecting previously isolated villages and cities. Hospitals may have played a role, too. Strapped for cash, some of them probably re-used dirty needles, unknowingly infecting patients in the process.

Are there other theories about how the virus could have gotten into humans?

There are several competing theories, ranging from implausible conspiracies to arguments grounded in extensive research. The best-known of the latter, the "OPV/AIDS" theory, was exhaustively detailed in the 1999 book The River, by author Edward Hooper. As many as a million Africans were given oral polio vaccines (OPV) between 1957 and 1960. Hooper says witnesses have told him that a few batches of those vaccines were "grown" in chimp cells at a lab in Kisangani, a city in the Democratic Republic of the Congo -- and that the chimp cells, and thus the vaccines, could have contained SIVs that jumped into humans. "There are highly significant correlations between the places where this vaccine was administered and the places where … AIDS first appeared on the planet four to 20 years later," Hooper says.

Scientists' best guess is that the precursor of the most common 'M' virus jumped from the Cameroon chimps to humans sometime before 1931.
The majority of HIV researchers subscribe to the bushmeat theory and raise several arguments against the OPV theory. Hahn's recent research confirming that HIV-1 M and N arose from Pan troglodytes troglodytes chimps in Cameroon presents one problem: The Kisangani lab is in the Democratic Republic of the Congo, and it's home to a different subspecies of chimp than the one that was the source of HIV-1 M and N. However, it is possible that the chimps used in the Kisangani experiments were not from the area. In the spring of 2006, Hooper found a paper indicating that at least one of eight chimps at the Kisangani lab was a Pan troglodytes troglodytes.

The 1959 sample also presents a problem for the OPV theory. Judging by how fast the virus mutates, it had already diverged significantly from its SIV ancestors by the time doctors extracted it from a patient. However, the African polio vaccination program had begun only two years earlier, so under the OPV theory, the virus would have had only those two years in which to evolve. Dr. Ho, who sequenced the sample, says it looks like the virus has been around a lot longer than that.

Proponents of each theory have acknowledged (albeit grudgingly) that the other is scientifically possible. In the last two years researchers have found that both "simian foamy viruses" and at least two types of retroviruses can and do jump from monkeys to humans via hunting and butchery. And no one doubts that a vaccine cultured in primate cells could be contaminated with a primate virus. Some early polio vaccines contained SV40, a simian virus discovered in 1960, and the RNA virus that causes Marburg hemorrhagic fever.

The question is not whether either scenario could have happened -- it's which one did. To truly disprove the OPV theory, Hahn says, researchers would have to find HIV-infected human tissue samples that predate the polio vaccine trials. To prove the OPV/AIDS theory, on the other hand, they'd have to find the ancestral SIV in batches of the vaccine that were made in Kisangani. Neither of those things has happened, and it's possible they never will.

Why do we care? Does all this research into how the virus got started tell us anything about how to stop it?


Hunting chimps in West Central Africa.
Research into the HIV's origins may eventually yield practical results. It could help scientists understand why HIV's viral ancestor, SIV, doesn't kill or even sicken chimps who carry it. With that knowledge, researchers might be able to make drugs with fewer side effects, or broad-spectrum vaccines that protect against all the strains of the disease that infect people today.

Korber suggests that in an era of emerging diseases, looking back on the virus' shadowy origins offers a "history lesson," or perhaps even a fable, with a moral attached. By the time doctors realized that HIV/AIDS existed, it had already taken up permanent residence in humans. They couldn't have known about it before then, but, Korber says, at least now they know to be wary as the virus continues its shape-shifting spread around the globe. "The fact that it could be with us for quite a long time before we even realized it was there is kind of eye-opening," she says. "I think it's something to keep us on our toes. It helps us understand that we can be surprised." And of course, HIV research may have a few surprises left for us, too.

Causes Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Day Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Day Aids biography

source (google.com.pk)
HIV-1, which is responsible for the vast majority of AIDS cases worldwide, is divided into three groups -- the "major" group M, and the much rarer "outlier" group O and "new" group N -- that have diverged over years of mutation and evolution. Within the M group -- which makes up 90 percent of all infections worldwide -- there are at least nine strains, known as "clades," of HIV-1 that are constantly mutating and merging with each other, creating yet more new varieties. "The M group epidemiologically has overwhelmed what else is out there," says Dr. Beatrice Hahn of the University of Alabama-Birmingham, who has conducted much of the research into HIV's origin. HIV-2, on the other hand, is not as virulent and largely confined to West Africa, where it originated.

In May 2006, an international group of researchers led by Hahn answered two major questions about the origin of HIV-1 M, the deadliest and most widespread form of the virus: Where was its cradle, and what kind of chimp did it come from? Answering the questions was literally messy work -- researchers collected 599 waste samples from wild chimpanzees and analyzed the viral particles they contained -- but the results were immaculate. Three populations of Pan troglodytes troglodytes living in southern Cameroon provided the crucial data. Two of those populations currently carry SIVs that are molecular dead ringers for HIV-1 M, while many chimps in the third group are infected with an SIV remarkably similar to HIV-1 N. Group O's simian sibling is probably lurking in other chimp populations in West Central Africa, says Hahn, adding that she has "a pretty good idea where it's going to be … and we're going to find it."

The research puts to rest decades of speculation about the birthplace of most types of HIV and their animal "reservoir" in the wild. But there are still many questions that haven't yet been definitively settled -- questions such as:

When did HIV-1 first start spreading in humans?

HIV-1 is surprisingly old, and it probably "debuted" in humans at least three separate times -- one for each subtype, M, N, and O. Scientists' best guess is that the precursor of the most common "M" virus jumped from the Cameroon chimps to humans sometime before 1931. Using samples of HIV-infected tissue harvested over the last three decades, virologist Dr. Bette Korber of Los Alamos National Laboratory has calculated that an ancestral form of HIV started spreading, slowly at first, in humans about 75 years ago. The actual jump from chimps to humans probably occurred shortly before that, says Hahn: "There's no reason to believe this was just lingering around in people."

Korber's model estimates a virus' age based on how extensively different strains have mutated. HIV is an unusual virus; it changes its DNA by both mutation and, more often, recombination, when two strains merge within the body and exchange genetic material. Some scientists refer to this process as "viral sex," and it may partially explain why it is so hard for scientists to make a treatment or vaccine. Korber's model does not take recombination into account, but given a virus' DNA configuration, it can roughly predict the age of that strain. Korber has tested the oldest known HIV sample, taken in 1959, and derived the 1931 estimate.

Why do scientists look at recent samples of HIV to determine the virus' overall age? Wouldn't it be better to use older samples that haven't had as much time to mutate?

It would, but scientists don't have that luxury. Other than the 1959 sample, there are very few preserved specimens of HIV-infected tissue that predate the early '80s, when the virus was first recognized by health authorities. Researchers still hope there are forgotten samples in African freezers. "There has to be some serum or plasma somewhere, and given modern technology we could fish out the virus," says Dr. David Ho, director of the Aaron Diamond AIDS Research Center and one of the world's leading authorities on HIV.

But even if those samples are found someday, they won't necessarily yield definite answers about the virus' age, says Korber: "Often, you can't get anything out of samples like that." Most African samples are made of blood serum, and serum samples contain viral RNA, which degrades much faster than the DNA found in tissue samples. In fact, says Ho, the 1959 sample, which was sequenced by his laboratory, was kept in a freezer but still didn't survive the ravages of time. "It was completely dried up," he says. "We were only able to get small pieces [of genetic material], and we had to stitch them together."

So scientists have estimated when and where the most deadly type of HIV started infecting humans -- but how did it do that?

Most AIDS researchers believe that the "bushmeat trade" allowed the HIV-1 virus, and separately HIV-2, to enter the human bloodstream several times. Hunters who kill and butcher chimps and monkeys are regularly exposed to animal blood teeming with SIVs. If the hunters have cuts, bites, or scratches -- and given the nature of their work they almost always do -- they can catch the viruses from their prey. Hunters going after chimps in Cameroon could have caught the first strains of HIV-1. Sooty mangabeys, hunted and kept as pets in West Africa, could have transmitted HIV-2 to humans.

Africans have hunted chimps and monkeys and kept them as pets for centuries; they've presumably been exposed to SIVs during most of that time. But the conditions needed for HIV to spread widely weren't in place until after the continent was colonized and urbanized. The first victims would have found it easier to unwittingly spread the virus to sexual partners far and wide as roads and vehicles started connecting previously isolated villages and cities. Hospitals may have played a role, too. Strapped for cash, some of them probably re-used dirty needles, unknowingly infecting patients in the process.

Are there other theories about how the virus could have gotten into humans?

There are several competing theories, ranging from implausible conspiracies to arguments grounded in extensive research. The best-known of the latter, the "OPV/AIDS" theory, was exhaustively detailed in the 1999 book The River, by author Edward Hooper. As many as a million Africans were given oral polio vaccines (OPV) between 1957 and 1960. Hooper says witnesses have told him that a few batches of those vaccines were "grown" in chimp cells at a lab in Kisangani, a city in the Democratic Republic of the Congo -- and that the chimp cells, and thus the vaccines, could have contained SIVs that jumped into humans. "There are highly significant correlations between the places where this vaccine was administered and the places where … AIDS first appeared on the planet four to 20 years later," Hooper says.

Scientists' best guess is that the precursor of the most common 'M' virus jumped from the Cameroon chimps to humans sometime before 1931.
The majority of HIV researchers subscribe to the bushmeat theory and raise several arguments against the OPV theory. Hahn's recent research confirming that HIV-1 M and N arose from Pan troglodytes troglodytes chimps in Cameroon presents one problem: The Kisangani lab is in the Democratic Republic of the Congo, and it's home to a different subspecies of chimp than the one that was the source of HIV-1 M and N. However, it is possible that the chimps used in the Kisangani experiments were not from the area. In the spring of 2006, Hooper found a paper indicating that at least one of eight chimps at the Kisangani lab was a Pan troglodytes troglodytes.

The 1959 sample also presents a problem for the OPV theory. Judging by how fast the virus mutates, it had already diverged significantly from its SIV ancestors by the time doctors extracted it from a patient. However, the African polio vaccination program had begun only two years earlier, so under the OPV theory, the virus would have had only those two years in which to evolve. Dr. Ho, who sequenced the sample, says it looks like the virus has been around a lot longer than that.

Proponents of each theory have acknowledged (albeit grudgingly) that the other is scientifically possible. In the last two years researchers have found that both "simian foamy viruses" and at least two types of retroviruses can and do jump from monkeys to humans via hunting and butchery. And no one doubts that a vaccine cultured in primate cells could be contaminated with a primate virus. Some early polio vaccines contained SV40, a simian virus discovered in 1960, and the RNA virus that causes Marburg hemorrhagic fever.

The question is not whether either scenario could have happened -- it's which one did. To truly disprove the OPV theory, Hahn says, researchers would have to find HIV-infected human tissue samples that predate the polio vaccine trials. To prove the OPV/AIDS theory, on the other hand, they'd have to find the ancestral SIV in batches of the vaccine that were made in Kisangani. Neither of those things has happened, and it's possible they never will.

Why do we care? Does all this research into how the virus got started tell us anything about how to stop it?


Hunting chimps in West Central Africa.
Research into the HIV's origins may eventually yield practical results. It could help scientists understand why HIV's viral ancestor, SIV, doesn't kill or even sicken chimps who carry it. With that knowledge, researchers might be able to make drugs with fewer side effects, or broad-spectrum vaccines that protect against all the strains of the disease that infect people today.

Korber suggests that in an era of emerging diseases, looking back on the virus' shadowy origins offers a "history lesson," or perhaps even a fable, with a moral attached. By the time doctors realized that HIV/AIDS existed, it had already taken up permanent residence in humans. They couldn't have known about it before then, but, Korber says, at least now they know to be wary as the virus continues its shape-shifting spread around the globe. "The fact that it could be with us for quite a long time before we even realized it was there is kind of eye-opening," she says. "I think it's something to keep us on our toes. It helps us understand that we can be surprised." And of course, HIV research may have a few surprises left for us, too.

Aids Day Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Facts About Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Facts About Aids biography

source (google.com.pk)
HIV-1, which is responsible for the vast majority of AIDS cases worldwide, is divided into three groups -- the "major" group M, and the much rarer "outlier" group O and "new" group N -- that have diverged over years of mutation and evolution. Within the M group -- which makes up 90 percent of all infections worldwide -- there are at least nine strains, known as "clades," of HIV-1 that are constantly mutating and merging with each other, creating yet more new varieties. "The M group epidemiologically has overwhelmed what else is out there," says Dr. Beatrice Hahn of the University of Alabama-Birmingham, who has conducted much of the research into HIV's origin. HIV-2, on the other hand, is not as virulent and largely confined to West Africa, where it originated.

In May 2006, an international group of researchers led by Hahn answered two major questions about the origin of HIV-1 M, the deadliest and most widespread form of the virus: Where was its cradle, and what kind of chimp did it come from? Answering the questions was literally messy work -- researchers collected 599 waste samples from wild chimpanzees and analyzed the viral particles they contained -- but the results were immaculate. Three populations of Pan troglodytes troglodytes living in southern Cameroon provided the crucial data. Two of those populations currently carry SIVs that are molecular dead ringers for HIV-1 M, while many chimps in the third group are infected with an SIV remarkably similar to HIV-1 N. Group O's simian sibling is probably lurking in other chimp populations in West Central Africa, says Hahn, adding that she has "a pretty good idea where it's going to be … and we're going to find it."

The research puts to rest decades of speculation about the birthplace of most types of HIV and their animal "reservoir" in the wild. But there are still many questions that haven't yet been definitively settled -- questions such as:

When did HIV-1 first start spreading in humans?

HIV-1 is surprisingly old, and it probably "debuted" in humans at least three separate times -- one for each subtype, M, N, and O. Scientists' best guess is that the precursor of the most common "M" virus jumped from the Cameroon chimps to humans sometime before 1931. Using samples of HIV-infected tissue harvested over the last three decades, virologist Dr. Bette Korber of Los Alamos National Laboratory has calculated that an ancestral form of HIV started spreading, slowly at first, in humans about 75 years ago. The actual jump from chimps to humans probably occurred shortly before that, says Hahn: "There's no reason to believe this was just lingering around in people."

Korber's model estimates a virus' age based on how extensively different strains have mutated. HIV is an unusual virus; it changes its DNA by both mutation and, more often, recombination, when two strains merge within the body and exchange genetic material. Some scientists refer to this process as "viral sex," and it may partially explain why it is so hard for scientists to make a treatment or vaccine. Korber's model does not take recombination into account, but given a virus' DNA configuration, it can roughly predict the age of that strain. Korber has tested the oldest known HIV sample, taken in 1959, and derived the 1931 estimate.

Why do scientists look at recent samples of HIV to determine the virus' overall age? Wouldn't it be better to use older samples that haven't had as much time to mutate?

It would, but scientists don't have that luxury. Other than the 1959 sample, there are very few preserved specimens of HIV-infected tissue that predate the early '80s, when the virus was first recognized by health authorities. Researchers still hope there are forgotten samples in African freezers. "There has to be some serum or plasma somewhere, and given modern technology we could fish out the virus," says Dr. David Ho, director of the Aaron Diamond AIDS Research Center and one of the world's leading authorities on HIV.

But even if those samples are found someday, they won't necessarily yield definite answers about the virus' age, says Korber: "Often, you can't get anything out of samples like that." Most African samples are made of blood serum, and serum samples contain viral RNA, which degrades much faster than the DNA found in tissue samples. In fact, says Ho, the 1959 sample, which was sequenced by his laboratory, was kept in a freezer but still didn't survive the ravages of time. "It was completely dried up," he says. "We were only able to get small pieces [of genetic material], and we had to stitch them together."

So scientists have estimated when and where the most deadly type of HIV started infecting humans -- but how did it do that?

Most AIDS researchers believe that the "bushmeat trade" allowed the HIV-1 virus, and separately HIV-2, to enter the human bloodstream several times. Hunters who kill and butcher chimps and monkeys are regularly exposed to animal blood teeming with SIVs. If the hunters have cuts, bites, or scratches -- and given the nature of their work they almost always do -- they can catch the viruses from their prey. Hunters going after chimps in Cameroon could have caught the first strains of HIV-1. Sooty mangabeys, hunted and kept as pets in West Africa, could have transmitted HIV-2 to humans.

Africans have hunted chimps and monkeys and kept them as pets for centuries; they've presumably been exposed to SIVs during most of that time. But the conditions needed for HIV to spread widely weren't in place until after the continent was colonized and urbanized. The first victims would have found it easier to unwittingly spread the virus to sexual partners far and wide as roads and vehicles started connecting previously isolated villages and cities. Hospitals may have played a role, too. Strapped for cash, some of them probably re-used dirty needles, unknowingly infecting patients in the process.

Are there other theories about how the virus could have gotten into humans?

There are several competing theories, ranging from implausible conspiracies to arguments grounded in extensive research. The best-known of the latter, the "OPV/AIDS" theory, was exhaustively detailed in the 1999 book The River, by author Edward Hooper. As many as a million Africans were given oral polio vaccines (OPV) between 1957 and 1960. Hooper says witnesses have told him that a few batches of those vaccines were "grown" in chimp cells at a lab in Kisangani, a city in the Democratic Republic of the Congo -- and that the chimp cells, and thus the vaccines, could have contained SIVs that jumped into humans. "There are highly significant correlations between the places where this vaccine was administered and the places where … AIDS first appeared on the planet four to 20 years later," Hooper says.

Scientists' best guess is that the precursor of the most common 'M' virus jumped from the Cameroon chimps to humans sometime before 1931.
The majority of HIV researchers subscribe to the bushmeat theory and raise several arguments against the OPV theory. Hahn's recent research confirming that HIV-1 M and N arose from Pan troglodytes troglodytes chimps in Cameroon presents one problem: The Kisangani lab is in the Democratic Republic of the Congo, and it's home to a different subspecies of chimp than the one that was the source of HIV-1 M and N. However, it is possible that the chimps used in the Kisangani experiments were not from the area. In the spring of 2006, Hooper found a paper indicating that at least one of eight chimps at the Kisangani lab was a Pan troglodytes troglodytes.

The 1959 sample also presents a problem for the OPV theory. Judging by how fast the virus mutates, it had already diverged significantly from its SIV ancestors by the time doctors extracted it from a patient. However, the African polio vaccination program had begun only two years earlier, so under the OPV theory, the virus would have had only those two years in which to evolve. Dr. Ho, who sequenced the sample, says it looks like the virus has been around a lot longer than that.

Proponents of each theory have acknowledged (albeit grudgingly) that the other is scientifically possible. In the last two years researchers have found that both "simian foamy viruses" and at least two types of retroviruses can and do jump from monkeys to humans via hunting and butchery. And no one doubts that a vaccine cultured in primate cells could be contaminated with a primate virus. Some early polio vaccines contained SV40, a simian virus discovered in 1960, and the RNA virus that causes Marburg hemorrhagic fever.

The question is not whether either scenario could have happened -- it's which one did. To truly disprove the OPV theory, Hahn says, researchers would have to find HIV-infected human tissue samples that predate the polio vaccine trials. To prove the OPV/AIDS theory, on the other hand, they'd have to find the ancestral SIV in batches of the vaccine that were made in Kisangani. Neither of those things has happened, and it's possible they never will.

Why do we care? Does all this research into how the virus got started tell us anything about how to stop it?


Hunting chimps in West Central Africa.
Research into the HIV's origins may eventually yield practical results. It could help scientists understand why HIV's viral ancestor, SIV, doesn't kill or even sicken chimps who carry it. With that knowledge, researchers might be able to make drugs with fewer side effects, or broad-spectrum vaccines that protect against all the strains of the disease that infect people today.

Korber suggests that in an era of emerging diseases, looking back on the virus' shadowy origins offers a "history lesson," or perhaps even a fable, with a moral attached. By the time doctors realized that HIV/AIDS existed, it had already taken up permanent residence in humans. They couldn't have known about it before then, but, Korber says, at least now they know to be wary as the virus continues its shape-shifting spread around the globe. "The fact that it could be with us for quite a long time before we even realized it was there is kind of eye-opening," she says. "I think it's something to keep us on our toes. It helps us understand that we can be surprised." And of course, HIV research may have a few surprises left for us, too.

Facts About Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

History Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Treatment For Aids biography

source (google.com.pk)
 The first African woman to win the Nobel Peace Prize, Wangari Maatha of Kenya, spoke out on the AIDS virus saying it was man-made and deliberately created as a weapon of bio-warfare.

"In fact it (the HIV virus) is created by a scientist for biological warfare,” she said. "Why has there been so much secrecy about AIDS? When you ask where did the virus come from, it raises a lot of flags. That makes me suspicious,” Maathai said.

The Kenya based East Africa Standard reported that in response to questions from Asian and European media, she said, "I want to dedicate the prize the African woman. I want to hold and embrace her. She has suffered so much and I feel this is an honor to her.

"Although I am a biologist, I have not done any research. I may not be able to say who developed the (HIV) virus but it was meant to wipe out the Black race," she continued.

"When she first blamed the HIV/Aids on 'some sadistic scientists, Professor Maathai kicked a storm, leaving some experts outraged and others supporting her," the Standard reported.

"Initially, said Maathai, HIV/Aids was only concentrated in selected spots in the continent, only afflicting the 'undesirable classes.' She insisted that some scientists from the developed world deliberately researched and developed the virus in order to "punish the Blacks".

"I cannot prove this but everybody knows that there are biological weapons. America invaded Iraq because they believed such weapons existed," said Maathai.

Africa accounts for 25 million out of the estimated 38 million people across the world infected with HIV/AIDS, and the vast majority of infected Africans are women, according to UNAIDS estimates.

“Some say that AIDS came from the monkeys, and I doubt that because we have been living with monkeys (since) time immemorial, others say it was a curse from God, but I say it cannot be that.

“Black people are dying more than any other people in this planet,” Maathai told a press conference in Nairobi a day after winning the prize for her work in human rights and reversing deforestation across Africa.

“It’s true that there are some people who create agents to wipe out other people. If there were no such people, we could have not have invaded Iraq,” she said.

“We invaded Iraq because we believed that Saddam Hussein had made, or was in the process of creating agents of biological warfare,” said Maathai, who is also the Kenyan Deputy Environment and Natural Resources Minister.

The unspoken truth is that both the United Nations and the United States have promoted so-called "population control" for decades. What better agent for the reduction of population than a man-made virus that will take care of millions of so-called "useless eaters"?

AIDS certainly fits the bill. But nobody is talking about its "efficiency."

END
Human Immunodeficiency Virus (HIV) is a lentivirus, a group of retroviruses, that causes slow development of acquired immunodeficiency syndrome (AIDS). This results in immune system failure and increased suscepibility to life-threatening infections. HIV occurs as two types: HIV-type 1 (HIV-1) and HIV-type 2 (HIV-2). The HIV-2 strain is limited to Western and Central Africa.[1] The HIV-1 type acts as the primary cause of (AIDS) throughout the world.[1] The focus of this text is on HIV-1. Virus transmission occurs through transfer of blood, vaginal fluid, semen, pre-ejaculate, or breast milk. The primary modes of transmission are unprotected sex, breast milk, contaminated needles, and transmission at birth by an infected mother.

The most recently reported prevalence in the United States of those living with diagnosed or undiagnosed HIV infection was 1.1 million adults and adolescents (prevalence rate: 447.8 per 100,000 population). [2] The latest number of new cases per year in the United States has been reported at an incidence of 56,300.[3]

Fold
Table of Contents
OVERVIEW
NORMAL IMMUNE SYSTEM
Innate Immunity
Adaptive Immunity
Humoral Immunity
Cell-Mediated Immunity
General Immune Response to Infection
Virus Structure - HIV
HIV Targets[1]
HIV Tropism
HIV Replication (See Fig. 1)
Step 1: Host cell binding and virus entry
Step 2: Uncoating the viral capsid
Step 3: Transcription
Step 4: Integration into host cell DNA
Step 5: Virus protein synthesis and assembly
Step 6: Exocytosis or storage within the host cell
Mutations and latency as inhibiting factors of complete HIV eradication
PATHOGENESIS OF HIV & IMMUNE RESPONSE
Immune Response to HIV-1
Cytokines
Mitochondria & Apoptosis in HIV infection
HIV and Neuroendocrine System
HPA Axis (See Fig. 3)
Cortisol
Adrenal Androgens
Heat Shock Proteins
Clinical Manifestations
Animal Models
Pharmacology
HIV Controllers vs. Progressors & Future Research
Conclusion
Comments
NORMAL IMMUNE SYSTEM

In order to thoroughly understand HIV/AIDs, it is paramount to understand the normal immune system response to infection and thus, how the HIV virus disrupts this system. The human body has typical physical barriers which protect us from pathogens including the gut, skin, urinary tract and mucous membranes of the bronchi. The organism is protected from infection and disease when the immune system is working properly; however, failure of the system can result in infection or disease that is localized or systemic. Due to the diversity of existing pathogens, the immune system has to respond in a variety of ways and the response depends on the type of antigen presented. Two immune responses work together to prevent entry of pathogens and destroy them upon penetration into the organism: Innate immunity and Adaptive/Acquired immunity.[4]

Innate Immunity

The innate immunity is the body’s first line of defense involving the skin and mucosal barriers as well as a nonspecific inflammatory response. [4] The main purpose of innate immunity is to rapidly contain an infection or pathogen once present in order to slow down the replication and spread of the pathogen. If the pathogen cannot be destroyed by the innate system alone, the adaptive immune system is mobilized. Once the adaptive response is initiated, the innate immunity also plays a critical role for amplifying, modulating, and sustaining the adaptive immune responses.[5]

History Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

History Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

History Of Aids biography

source (google.com.pk)
HIV-1, which is responsible for the vast majority of AIDS cases worldwide, is divided into three groups -- the "major" group M, and the much rarer "outlier" group O and "new" group N -- that have diverged over years of mutation and evolution. Within the M group -- which makes up 90 percent of all infections worldwide -- there are at least nine strains, known as "clades," of HIV-1 that are constantly mutating and merging with each other, creating yet more new varieties. "The M group epidemiologically has overwhelmed what else is out there," says Dr. Beatrice Hahn of the University of Alabama-Birmingham, who has conducted much of the research into HIV's origin. HIV-2, on the other hand, is not as virulent and largely confined to West Africa, where it originated.

In May 2006, an international group of researchers led by Hahn answered two major questions about the origin of HIV-1 M, the deadliest and most widespread form of the virus: Where was its cradle, and what kind of chimp did it come from? Answering the questions was literally messy work -- researchers collected 599 waste samples from wild chimpanzees and analyzed the viral particles they contained -- but the results were immaculate. Three populations of Pan troglodytes troglodytes living in southern Cameroon provided the crucial data. Two of those populations currently carry SIVs that are molecular dead ringers for HIV-1 M, while many chimps in the third group are infected with an SIV remarkably similar to HIV-1 N. Group O's simian sibling is probably lurking in other chimp populations in West Central Africa, says Hahn, adding that she has "a pretty good idea where it's going to be … and we're going to find it."

The research puts to rest decades of speculation about the birthplace of most types of HIV and their animal "reservoir" in the wild. But there are still many questions that haven't yet been definitively settled -- questions such as:

When did HIV-1 first start spreading in humans?

HIV-1 is surprisingly old, and it probably "debuted" in humans at least three separate times -- one for each subtype, M, N, and O. Scientists' best guess is that the precursor of the most common "M" virus jumped from the Cameroon chimps to humans sometime before 1931. Using samples of HIV-infected tissue harvested over the last three decades, virologist Dr. Bette Korber of Los Alamos National Laboratory has calculated that an ancestral form of HIV started spreading, slowly at first, in humans about 75 years ago. The actual jump from chimps to humans probably occurred shortly before that, says Hahn: "There's no reason to believe this was just lingering around in people."

Korber's model estimates a virus' age based on how extensively different strains have mutated. HIV is an unusual virus; it changes its DNA by both mutation and, more often, recombination, when two strains merge within the body and exchange genetic material. Some scientists refer to this process as "viral sex," and it may partially explain why it is so hard for scientists to make a treatment or vaccine. Korber's model does not take recombination into account, but given a virus' DNA configuration, it can roughly predict the age of that strain. Korber has tested the oldest known HIV sample, taken in 1959, and derived the 1931 estimate.

Why do scientists look at recent samples of HIV to determine the virus' overall age? Wouldn't it be better to use older samples that haven't had as much time to mutate?

It would, but scientists don't have that luxury. Other than the 1959 sample, there are very few preserved specimens of HIV-infected tissue that predate the early '80s, when the virus was first recognized by health authorities. Researchers still hope there are forgotten samples in African freezers. "There has to be some serum or plasma somewhere, and given modern technology we could fish out the virus," says Dr. David Ho, director of the Aaron Diamond AIDS Research Center and one of the world's leading authorities on HIV.

But even if those samples are found someday, they won't necessarily yield definite answers about the virus' age, says Korber: "Often, you can't get anything out of samples like that." Most African samples are made of blood serum, and serum samples contain viral RNA, which degrades much faster than the DNA found in tissue samples. In fact, says Ho, the 1959 sample, which was sequenced by his laboratory, was kept in a freezer but still didn't survive the ravages of time. "It was completely dried up," he says. "We were only able to get small pieces [of genetic material], and we had to stitch them together."

So scientists have estimated when and where the most deadly type of HIV started infecting humans -- but how did it do that?

Most AIDS researchers believe that the "bushmeat trade" allowed the HIV-1 virus, and separately HIV-2, to enter the human bloodstream several times. Hunters who kill and butcher chimps and monkeys are regularly exposed to animal blood teeming with SIVs. If the hunters have cuts, bites, or scratches -- and given the nature of their work they almost always do -- they can catch the viruses from their prey. Hunters going after chimps in Cameroon could have caught the first strains of HIV-1. Sooty mangabeys, hunted and kept as pets in West Africa, could have transmitted HIV-2 to humans.

Africans have hunted chimps and monkeys and kept them as pets for centuries; they've presumably been exposed to SIVs during most of that time. But the conditions needed for HIV to spread widely weren't in place until after the continent was colonized and urbanized. The first victims would have found it easier to unwittingly spread the virus to sexual partners far and wide as roads and vehicles started connecting previously isolated villages and cities. Hospitals may have played a role, too. Strapped for cash, some of them probably re-used dirty needles, unknowingly infecting patients in the process.

Are there other theories about how the virus could have gotten into humans?

There are several competing theories, ranging from implausible conspiracies to arguments grounded in extensive research. The best-known of the latter, the "OPV/AIDS" theory, was exhaustively detailed in the 1999 book The River, by author Edward Hooper. As many as a million Africans were given oral polio vaccines (OPV) between 1957 and 1960. Hooper says witnesses have told him that a few batches of those vaccines were "grown" in chimp cells at a lab in Kisangani, a city in the Democratic Republic of the Congo -- and that the chimp cells, and thus the vaccines, could have contained SIVs that jumped into humans. "There are highly significant correlations between the places where this vaccine was administered and the places where … AIDS first appeared on the planet four to 20 years later," Hooper says.

Scientists' best guess is that the precursor of the most common 'M' virus jumped from the Cameroon chimps to humans sometime before 1931.
The majority of HIV researchers subscribe to the bushmeat theory and raise several arguments against the OPV theory. Hahn's recent research confirming that HIV-1 M and N arose from Pan troglodytes troglodytes chimps in Cameroon presents one problem: The Kisangani lab is in the Democratic Republic of the Congo, and it's home to a different subspecies of chimp than the one that was the source of HIV-1 M and N. However, it is possible that the chimps used in the Kisangani experiments were not from the area. In the spring of 2006, Hooper found a paper indicating that at least one of eight chimps at the Kisangani lab was a Pan troglodytes troglodytes.

The 1959 sample also presents a problem for the OPV theory. Judging by how fast the virus mutates, it had already diverged significantly from its SIV ancestors by the time doctors extracted it from a patient. However, the African polio vaccination program had begun only two years earlier, so under the OPV theory, the virus would have had only those two years in which to evolve. Dr. Ho, who sequenced the sample, says it looks like the virus has been around a lot longer than that.

Proponents of each theory have acknowledged (albeit grudgingly) that the other is scientifically possible. In the last two years researchers have found that both "simian foamy viruses" and at least two types of retroviruses can and do jump from monkeys to humans via hunting and butchery. And no one doubts that a vaccine cultured in primate cells could be contaminated with a primate virus. Some early polio vaccines contained SV40, a simian virus discovered in 1960, and the RNA virus that causes Marburg hemorrhagic fever.

The question is not whether either scenario could have happened -- it's which one did. To truly disprove the OPV theory, Hahn says, researchers would have to find HIV-infected human tissue samples that predate the polio vaccine trials. To prove the OPV/AIDS theory, on the other hand, they'd have to find the ancestral SIV in batches of the vaccine that were made in Kisangani. Neither of those things has happened, and it's possible they never will.

Why do we care? Does all this research into how the virus got started tell us anything about how to stop it?


Hunting chimps in West Central Africa.
Research into the HIV's origins may eventually yield practical results. It could help scientists understand why HIV's viral ancestor, SIV, doesn't kill or even sicken chimps who carry it. With that knowledge, researchers might be able to make drugs with fewer side effects, or broad-spectrum vaccines that protect against all the strains of the disease that infect people today.

Korber suggests that in an era of emerging diseases, looking back on the virus' shadowy origins offers a "history lesson," or perhaps even a fable, with a moral attached. By the time doctors realized that HIV/AIDS existed, it had already taken up permanent residence in humans. They couldn't have known about it before then, but, Korber says, at least now they know to be wary as the virus continues its shape-shifting spread around the globe. "The fact that it could be with us for quite a long time before we even realized it was there is kind of eye-opening," she says. "I think it's something to keep us on our toes. It helps us understand that we can be surprised." And of course, HIV research may have a few surprises left for us, too.

History Of Aids Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Info Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Info biography

source (google.com.pk)
 The first African woman to win the Nobel Peace Prize, Wangari Maatha of Kenya, spoke out on the AIDS virus saying it was man-made and deliberately created as a weapon of bio-warfare.

"In fact it (the HIV virus) is created by a scientist for biological warfare,” she said. "Why has there been so much secrecy about AIDS? When you ask where did the virus come from, it raises a lot of flags. That makes me suspicious,” Maathai said.

The Kenya based East Africa Standard reported that in response to questions from Asian and European media, she said, "I want to dedicate the prize the African woman. I want to hold and embrace her. She has suffered so much and I feel this is an honor to her.

"Although I am a biologist, I have not done any research. I may not be able to say who developed the (HIV) virus but it was meant to wipe out the Black race," she continued.

"When she first blamed the HIV/Aids on 'some sadistic scientists, Professor Maathai kicked a storm, leaving some experts outraged and others supporting her," the Standard reported.

"Initially, said Maathai, HIV/Aids was only concentrated in selected spots in the continent, only afflicting the 'undesirable classes.' She insisted that some scientists from the developed world deliberately researched and developed the virus in order to "punish the Blacks".

"I cannot prove this but everybody knows that there are biological weapons. America invaded Iraq because they believed such weapons existed," said Maathai.

Africa accounts for 25 million out of the estimated 38 million people across the world infected with HIV/AIDS, and the vast majority of infected Africans are women, according to UNAIDS estimates.

“Some say that AIDS came from the monkeys, and I doubt that because we have been living with monkeys (since) time immemorial, others say it was a curse from God, but I say it cannot be that.

“Black people are dying more than any other people in this planet,” Maathai told a press conference in Nairobi a day after winning the prize for her work in human rights and reversing deforestation across Africa.

“It’s true that there are some people who create agents to wipe out other people. If there were no such people, we could have not have invaded Iraq,” she said.

“We invaded Iraq because we believed that Saddam Hussein had made, or was in the process of creating agents of biological warfare,” said Maathai, who is also the Kenyan Deputy Environment and Natural Resources Minister.

The unspoken truth is that both the United Nations and the United States have promoted so-called "population control" for decades. What better agent for the reduction of population than a man-made virus that will take care of millions of so-called "useless eaters"?

AIDS certainly fits the bill. But nobody is talking about its "efficiency."

END
Human Immunodeficiency Virus (HIV) is a lentivirus, a group of retroviruses, that causes slow development of acquired immunodeficiency syndrome (AIDS). This results in immune system failure and increased suscepibility to life-threatening infections. HIV occurs as two types: HIV-type 1 (HIV-1) and HIV-type 2 (HIV-2). The HIV-2 strain is limited to Western and Central Africa.[1] The HIV-1 type acts as the primary cause of (AIDS) throughout the world.[1] The focus of this text is on HIV-1. Virus transmission occurs through transfer of blood, vaginal fluid, semen, pre-ejaculate, or breast milk. The primary modes of transmission are unprotected sex, breast milk, contaminated needles, and transmission at birth by an infected mother.

The most recently reported prevalence in the United States of those living with diagnosed or undiagnosed HIV infection was 1.1 million adults and adolescents (prevalence rate: 447.8 per 100,000 population). [2] The latest number of new cases per year in the United States has been reported at an incidence of 56,300.[3]

Fold
Table of Contents
OVERVIEW
NORMAL IMMUNE SYSTEM
Innate Immunity
Adaptive Immunity
Humoral Immunity
Cell-Mediated Immunity
General Immune Response to Infection
Virus Structure - HIV
HIV Targets[1]
HIV Tropism
HIV Replication (See Fig. 1)
Step 1: Host cell binding and virus entry
Step 2: Uncoating the viral capsid
Step 3: Transcription
Step 4: Integration into host cell DNA
Step 5: Virus protein synthesis and assembly
Step 6: Exocytosis or storage within the host cell
Mutations and latency as inhibiting factors of complete HIV eradication
PATHOGENESIS OF HIV & IMMUNE RESPONSE
Immune Response to HIV-1
Cytokines
Mitochondria & Apoptosis in HIV infection
HIV and Neuroendocrine System
HPA Axis (See Fig. 3)
Cortisol
Adrenal Androgens
Heat Shock Proteins
Clinical Manifestations
Animal Models
Pharmacology
HIV Controllers vs. Progressors & Future Research
Conclusion
Comments
NORMAL IMMUNE SYSTEM

In order to thoroughly understand HIV/AIDs, it is paramount to understand the normal immune system response to infection and thus, how the HIV virus disrupts this system. The human body has typical physical barriers which protect us from pathogens including the gut, skin, urinary tract and mucous membranes of the bronchi. The organism is protected from infection and disease when the immune system is working properly; however, failure of the system can result in infection or disease that is localized or systemic. Due to the diversity of existing pathogens, the immune system has to respond in a variety of ways and the response depends on the type of antigen presented. Two immune responses work together to prevent entry of pathogens and destroy them upon penetration into the organism: Innate immunity and Adaptive/Acquired immunity.[4]

Innate Immunity

The innate immunity is the body’s first line of defense involving the skin and mucosal barriers as well as a nonspecific inflammatory response. [4] The main purpose of innate immunity is to rapidly contain an infection or pathogen once present in order to slow down the replication and spread of the pathogen. If the pathogen cannot be destroyed by the innate system alone, the adaptive immune system is mobilized. Once the adaptive response is initiated, the innate immunity also plays a critical role for amplifying, modulating, and sustaining the adaptive immune responses.[5]

Aids Info Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Statistics Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos

Aids Statistics biography

source (google.com.pk)
HIV-1, which is responsible for the vast majority of AIDS cases worldwide, is divided into three groups -- the "major" group M, and the much rarer "outlier" group O and "new" group N -- that have diverged over years of mutation and evolution. Within the M group -- which makes up 90 percent of all infections worldwide -- there are at least nine strains, known as "clades," of HIV-1 that are constantly mutating and merging with each other, creating yet more new varieties. "The M group epidemiologically has overwhelmed what else is out there," says Dr. Beatrice Hahn of the University of Alabama-Birmingham, who has conducted much of the research into HIV's origin. HIV-2, on the other hand, is not as virulent and largely confined to West Africa, where it originated.

In May 2006, an international group of researchers led by Hahn answered two major questions about the origin of HIV-1 M, the deadliest and most widespread form of the virus: Where was its cradle, and what kind of chimp did it come from? Answering the questions was literally messy work -- researchers collected 599 waste samples from wild chimpanzees and analyzed the viral particles they contained -- but the results were immaculate. Three populations of Pan troglodytes troglodytes living in southern Cameroon provided the crucial data. Two of those populations currently carry SIVs that are molecular dead ringers for HIV-1 M, while many chimps in the third group are infected with an SIV remarkably similar to HIV-1 N. Group O's simian sibling is probably lurking in other chimp populations in West Central Africa, says Hahn, adding that she has "a pretty good idea where it's going to be … and we're going to find it."

The research puts to rest decades of speculation about the birthplace of most types of HIV and their animal "reservoir" in the wild. But there are still many questions that haven't yet been definitively settled -- questions such as:

When did HIV-1 first start spreading in humans?

HIV-1 is surprisingly old, and it probably "debuted" in humans at least three separate times -- one for each subtype, M, N, and O. Scientists' best guess is that the precursor of the most common "M" virus jumped from the Cameroon chimps to humans sometime before 1931. Using samples of HIV-infected tissue harvested over the last three decades, virologist Dr. Bette Korber of Los Alamos National Laboratory has calculated that an ancestral form of HIV started spreading, slowly at first, in humans about 75 years ago. The actual jump from chimps to humans probably occurred shortly before that, says Hahn: "There's no reason to believe this was just lingering around in people."

Korber's model estimates a virus' age based on how extensively different strains have mutated. HIV is an unusual virus; it changes its DNA by both mutation and, more often, recombination, when two strains merge within the body and exchange genetic material. Some scientists refer to this process as "viral sex," and it may partially explain why it is so hard for scientists to make a treatment or vaccine. Korber's model does not take recombination into account, but given a virus' DNA configuration, it can roughly predict the age of that strain. Korber has tested the oldest known HIV sample, taken in 1959, and derived the 1931 estimate.

Why do scientists look at recent samples of HIV to determine the virus' overall age? Wouldn't it be better to use older samples that haven't had as much time to mutate?

It would, but scientists don't have that luxury. Other than the 1959 sample, there are very few preserved specimens of HIV-infected tissue that predate the early '80s, when the virus was first recognized by health authorities. Researchers still hope there are forgotten samples in African freezers. "There has to be some serum or plasma somewhere, and given modern technology we could fish out the virus," says Dr. David Ho, director of the Aaron Diamond AIDS Research Center and one of the world's leading authorities on HIV.

But even if those samples are found someday, they won't necessarily yield definite answers about the virus' age, says Korber: "Often, you can't get anything out of samples like that." Most African samples are made of blood serum, and serum samples contain viral RNA, which degrades much faster than the DNA found in tissue samples. In fact, says Ho, the 1959 sample, which was sequenced by his laboratory, was kept in a freezer but still didn't survive the ravages of time. "It was completely dried up," he says. "We were only able to get small pieces [of genetic material], and we had to stitch them together."

So scientists have estimated when and where the most deadly type of HIV started infecting humans -- but how did it do that?

Most AIDS researchers believe that the "bushmeat trade" allowed the HIV-1 virus, and separately HIV-2, to enter the human bloodstream several times. Hunters who kill and butcher chimps and monkeys are regularly exposed to animal blood teeming with SIVs. If the hunters have cuts, bites, or scratches -- and given the nature of their work they almost always do -- they can catch the viruses from their prey. Hunters going after chimps in Cameroon could have caught the first strains of HIV-1. Sooty mangabeys, hunted and kept as pets in West Africa, could have transmitted HIV-2 to humans.

Africans have hunted chimps and monkeys and kept them as pets for centuries; they've presumably been exposed to SIVs during most of that time. But the conditions needed for HIV to spread widely weren't in place until after the continent was colonized and urbanized. The first victims would have found it easier to unwittingly spread the virus to sexual partners far and wide as roads and vehicles started connecting previously isolated villages and cities. Hospitals may have played a role, too. Strapped for cash, some of them probably re-used dirty needles, unknowingly infecting patients in the process.

Are there other theories about how the virus could have gotten into humans?

There are several competing theories, ranging from implausible conspiracies to arguments grounded in extensive research. The best-known of the latter, the "OPV/AIDS" theory, was exhaustively detailed in the 1999 book The River, by author Edward Hooper. As many as a million Africans were given oral polio vaccines (OPV) between 1957 and 1960. Hooper says witnesses have told him that a few batches of those vaccines were "grown" in chimp cells at a lab in Kisangani, a city in the Democratic Republic of the Congo -- and that the chimp cells, and thus the vaccines, could have contained SIVs that jumped into humans. "There are highly significant correlations between the places where this vaccine was administered and the places where … AIDS first appeared on the planet four to 20 years later," Hooper says.

Scientists' best guess is that the precursor of the most common 'M' virus jumped from the Cameroon chimps to humans sometime before 1931.
The majority of HIV researchers subscribe to the bushmeat theory and raise several arguments against the OPV theory. Hahn's recent research confirming that HIV-1 M and N arose from Pan troglodytes troglodytes chimps in Cameroon presents one problem: The Kisangani lab is in the Democratic Republic of the Congo, and it's home to a different subspecies of chimp than the one that was the source of HIV-1 M and N. However, it is possible that the chimps used in the Kisangani experiments were not from the area. In the spring of 2006, Hooper found a paper indicating that at least one of eight chimps at the Kisangani lab was a Pan troglodytes troglodytes.

The 1959 sample also presents a problem for the OPV theory. Judging by how fast the virus mutates, it had already diverged significantly from its SIV ancestors by the time doctors extracted it from a patient. However, the African polio vaccination program had begun only two years earlier, so under the OPV theory, the virus would have had only those two years in which to evolve. Dr. Ho, who sequenced the sample, says it looks like the virus has been around a lot longer than that.

Proponents of each theory have acknowledged (albeit grudgingly) that the other is scientifically possible. In the last two years researchers have found that both "simian foamy viruses" and at least two types of retroviruses can and do jump from monkeys to humans via hunting and butchery. And no one doubts that a vaccine cultured in primate cells could be contaminated with a primate virus. Some early polio vaccines contained SV40, a simian virus discovered in 1960, and the RNA virus that causes Marburg hemorrhagic fever.

The question is not whether either scenario could have happened -- it's which one did. To truly disprove the OPV theory, Hahn says, researchers would have to find HIV-infected human tissue samples that predate the polio vaccine trials. To prove the OPV/AIDS theory, on the other hand, they'd have to find the ancestral SIV in batches of the vaccine that were made in Kisangani. Neither of those things has happened, and it's possible they never will.

Why do we care? Does all this research into how the virus got started tell us anything about how to stop it?


Hunting chimps in West Central Africa.
Research into the HIV's origins may eventually yield practical results. It could help scientists understand why HIV's viral ancestor, SIV, doesn't kill or even sicken chimps who carry it. With that knowledge, researchers might be able to make drugs with fewer side effects, or broad-spectrum vaccines that protect against all the strains of the disease that infect people today.

Korber suggests that in an era of emerging diseases, looking back on the virus' shadowy origins offers a "history lesson," or perhaps even a fable, with a moral attached. By the time doctors realized that HIV/AIDS existed, it had already taken up permanent residence in humans. They couldn't have known about it before then, but, Korber says, at least now they know to be wary as the virus continues its shape-shifting spread around the globe. "The fact that it could be with us for quite a long time before we even realized it was there is kind of eye-opening," she says. "I think it's something to keep us on our toes. It helps us understand that we can be surprised." And of course, HIV research may have a few surprises left for us, too.

Aids Statistics Aids Symptoms Patient Virus Lesions Ribbon Rash Pictures i n Africa Symbol Victims Images pictures wallpapers photos